A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine
This study has been completed.
Sponsor:
Endo Pharmaceuticals
Collaborator:
Vernalis (R&D) Ltd
Information provided by:
Endo Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00644033
First received: March 24, 2008
Last updated: June 13, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2002 |
| Primary Completion Date: | June 2002 (Final data collection date for primary outcome measure) |
No publications provided by Endo Pharmaceuticals
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):